Safety and efficacy of sorafenib in patients with castrate resistant prostate cancer: A Phase II study
2010 ◽
Vol 28
(1)
◽
pp. 21-27
◽
Keyword(s):
Phase Ii
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. TPS241-TPS241
2008 ◽
Vol 26
(15_suppl)
◽
pp. 3005-3005
◽